Japan's Pharma Majors Invest $713 Million in API Projects

---

Researched by Industrial Info Resources (Sugar Land, Texas)--Industrial Info is tracking 18 projects in Japan's Pharmaceutical & Biotech Industry that are related to the production of active pharmaceutical ingredients (API), totaling more than US$713 million in investment value. These include grassroot, plant expansion, equipment replacement and maintenance projects.

Many Japanese pharmaceutical majors are expanding their facilities for active pharmaceutical ingredient (API) production for COVID-19 vaccines and treatment. Subscribers to Industrial Info's Global Market Intelligence (GMI) Pharmaceutical & Biotech Project Database can click here for a list of detailed project reports.

Click on the image at right for a heat map of API projects across Japan, from Industrial Info's Geolocator tool.

Industrial Info Resources (IIR) is the world's leading provider of market intelligence across the upstream, midstream and downstream energy markets and all other major industrial markets. IIR's Global Market Intelligence Platform (GMI) supports our end-users across their core businesses, and helps them connect trends across multiple markets with access to real, qualified and validated project opportunities. Follow IIR on: LinkedIn.